Lancet retracts 2006 infant opioid case report after falsification finding

The Lancet has retracted a 2006 case report describing the death of a baby boy from opioid poisoning via breast milk, after an investigation by Toronto's Hospital for Sick Children concluded that the authors falsified the report by omitting key data.

The report's first author was pharmacologist Gideon Koren of the Hospital for Sick Children in Toronto. The case described a baby boy whose mother had been prescribed Tylenol with codeine, an opiate that gets metabolized to morphine in the body. Koren used the case to claim for years that codeine can pose a lethal risk to breastfeeding infants.

The Lancet said it received new allegations on Jan. 20, 2026, that important toxicology data were left out of the paper. Those data included concentrations in the infant's blood of codeine and acetaminophen, and the contents of the baby's stomach. The journal referred the allegations to SickKids, which conducted a formal inquiry and reviewed new evidence.

A hospital spokesperson said the inquiry determined that material toxicology data had been omitted and that the omissions could prevent readers from properly evaluating the paper's conclusions. The retraction notice said the inquiry found that the omission constituted falsification.

The report has been cited 464 times, according to Clarivate's Web of Science. It was among the studies cited in a 2017 U.S. Food and Drug Administration safety announcement recommending against prescribing codeine to women who are breastfeeding. Koren was an author on seven of the 19 papers cited in support of that recommendation, including the retracted report.

Pharmacologist David Juurlink, professor of medicine and pediatrics at the University of Toronto, told Retraction Watch: "It is the foundational document in an entire branch of pediatric pharmacology that's just been made up out of whole cloth." Juurlink and pharmacologist Jonathan Zipursky published a 2020 review concluding that morphine toxicity from breast milk was unlikely, noting that the morphine concentration in a sample of the mother's milk was relatively low and that the infant's codeine blood concentration was about 100 times higher than would be expected from exposure through breast milk.

The case received renewed attention in January after an article in the New Yorker discussed autopsy findings and other evidence raising questions about whether the infant may have been given the pain medication directly rather than receiving it through breast milk. Parvaz Madadi, a former doctoral student in Koren's laboratory, wrote to The Lancet in January alleging that Koren falsified the infant's toxicology data and asked the journal to retract the case report.

Koren resigned from the Hospital for Sick Children in 2015 following an investigation into Motherisk, a lab he founded that tested for perinatal exposure to drugs and alcohol. The investigation, prompted by coverage in the Toronto Star, found the Motherisk lab's test results were "inadequate and unreliable," the newspaper reported. Following the investigation, more than 400 of Koren's papers came under scrutiny by the hospital. Koren has six previous retractions, two of which were papers on the safety of codeine while breastfeeding.


Sources

This article was drafted with AI assistance and checked against the sources above. Company claims are reported as claims. Cover image is AI-generated.